Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Short-term Investments · Q2 FY2026 · quarter ended Jun 2026
Short-term investments of $220.09M in Q2 FY2026
Q2 FY2026 short-term investments was $220.09M.
Context
- Short-term investments amounted to 47.1% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 97.51M USD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 97.51M | — |
Short-term Investments vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 short-term investments of $220.09M is the 3rd highest of the 5 companies compared; the peer median is $226.03M.
- Short-term investments amounts to 47.1% of total assets for COAG, versus a peer median of 33.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IRONDisc Medicine, Inc. | Sep 2026 | $592.83M | +24.7% | — | 84.8% |
| Mar 2026 | $446.56M | +132.8% | +63.2% | 57.3% | |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $220.09M | — | — | 47.1% |
| Mar 2026 | $5.5M | -86.2% | -40.7% | 10.1% | |
DMRADamora Therapeutics, Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding COAG) | $226.03M | +24.7% | +11.2% | 33.7% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.